An analytical procedure suitable for the analysis of 30 mycotoxins in fruit juice is presented. The Estimate Daily Intakes reached considerable percentages of Tolerable Daily Intake for children.

1. Introduction {#sec1-toxins-11-00684}
===============

Fruit juices are excellent source of antioxidants, vitamins, and minerals, which play an important role in the prevention of heart diseases, cancer, and diabetes. The consumption of fruit juices is trendy nowadays, to meet the goals of five daily serving of fruits and vegetables. Fruit juices are mainly consumed by children and seekers of higher-quality diets due to their freshness, high vitamin content, and low caloric intake \[[@B1-toxins-11-00684]\].

Moulds can infect agricultural crops during growth, harvest, storage, and processing. The fungal growth and the further mycotoxin production in fruits depend on various environmental factors such as moisture content, temperature and pH. Water activity of fruits boost fungal growth as many of them still tolerate the acidic pH of natural acids as citric, malic and tartaric acids \[[@B2-toxins-11-00684]\].

Furthermore, some environmental conditions such as insect infestation, drought, cultivar susceptibility, mechanical damage, rainfall or humidity can promote the mycotoxins production in crops. *Alternaria* spp., *Aspergillus* spp., *Fusarium* spp., and *Penicillum* spp. are the most common postharvest and storage fungi of fruits \[[@B1-toxins-11-00684]\].

Aflatoxins (AFs), ochratoxin A (OTA), patulin (PAT) and the *Alternaria* toxins such as alternariol (AOH), alternariol methyl ether (AME) and altenuene (ALT) are the most common mycotoxins reported in fruits and their processed products \[[@B3-toxins-11-00684],[@B4-toxins-11-00684],[@B5-toxins-11-00684],[@B6-toxins-11-00684],[@B7-toxins-11-00684],[@B8-toxins-11-00684],[@B9-toxins-11-00684]\].

Mycotoxins, secondary fungi metabolites are related to different health adverse effects, such as cancer induction, mutagenicity, estrogenicity as well as gastrointestinal, urogenital, vascular, kidney and nervous disorders \[[@B10-toxins-11-00684]\]. Mycotoxins showed stability against heat processes, which make its occurrence in processed juice highly likely expected \[[@B11-toxins-11-00684]\]. A careful selection of fruits, a proper storage, physical, chemical and biological detoxification methods are some strategies that are adopted to reduce the presence of mycotoxins in fruits \[[@B1-toxins-11-00684],[@B2-toxins-11-00684]\].

The European Union Commission has set permissible maximum limits to control the contents of mycotoxins in fruit juices \[[@B12-toxins-11-00684]\]. For OTA, 2 µg/kg have been established as maximum limit in grape juice, grape nectar, and its concentrated. In the case of PAT, 50 µg/kg have been set in fruit juices, its concentrated and fruits nectars while 10 µg/kg is the maximum established for apple juice and solid apple products, including apple compote and apple puree used by infants and young children. In the case of AFs, maximum limits have been established in dried fruits, but no AFs limits were set in fruit juices. *Alternaria* mycotoxins have been not regulated yet, despite some authors reported the toxicological implications of their presence in fruit juices \[[@B13-toxins-11-00684]\].

Although patulin is the most studied mycotoxin in fruits and their processed products, the presence of *Alternaria* toxins, aflatoxins and ochratoxin A has also been reported \[[@B1-toxins-11-00684]\]. These compounds can be of concern for human health due to their toxicity and the high consumption of juices by the young population, so multimycotoxin occurrence study in different types of juice available in the market will contribute to more realistic risk estimation.

Most methods for mycotoxins extraction involved liquid-liquid extraction, solid phase extraction using C18 cartridges and immunoaffinity clean-up columns to pre-concentrate and purify mycotoxins in food matrices. A dispersive liquid-liquid microextraction (DLLME) has also been developed for the purpose of miniaturizing, simplifying and automating the analytical procedure with good results \[[@B14-toxins-11-00684]\]. DLLME is a ternary component system formed by an aqueous solution, an organic extraction solvent (frequent solvent with high density) and a dispersive solvent (miscible in both of extractant and aqueous phases). DLLME has already proved some advantages such as high recoveries and low-cost applications \[[@B9-toxins-11-00684],[@B15-toxins-11-00684],[@B16-toxins-11-00684]\].

The aim of the present study was to evaluate the presence of 30 mycotoxins (AFB1, AFB2, AFG1, AFG2, AOH, AME, OTA, FB1, FB2, ENNA, ENNA1, ENNB, ENNB1, BEA, STG, ZEA, α-ZAL, β-ZAL, α-ZOL, β-ZOL, DON, 3-ADON, 15-ADON, DAS, NIV, FUS-X, NEO, PAT,T-2 and HT-2 toxins) in 80 fruit juice samples by Dispersive Liquid-Liquid Microextraction method (DLLME) and gas and liquid chromatography-tandem mass spectrometry determination. Liquid chromatography coupled to tandem mass spectrometry was used for the analysis of AFB1, AFB2, AFG1, AFG2, AOH, AME, OTA, FB1, FB2, ENNA, ENNA1, ENNB, ENNB1, BEA, STG while gas chromatography coupled to tandem mass spectrometry was used for the analysis of ZON, α-ZAL, β-ZAL, α-ZOL, β-ZOL, DON, 3-ADON, 15-ADON, DAS, NIV, FUS-X, NEO, PAT,T-2 and HT-2. Furthermore, the exposure to mycotoxins in adults and children population through the consumption of fruit juices was evaluated.

2. Results and Discussion {#sec2-toxins-11-00684}
=========================

2.1. Method Validation {#sec2dot1-toxins-11-00684}
----------------------

The method was validated in terms of recoveries, repeatability (intra-day precision), intermediate precision (inter-day precision), matrix effects, limits of detection (LODs), limits of quantification (LOQs) and linearity according to European Commission \[[@B17-toxins-11-00684]\]. The results are shown in [Table 1](#toxins-11-00684-t001){ref-type="table"}.

The acquisition by the triple quadrupole detector of two SRM transitions per compound accomplished the requirements set by the Commission Decision 2002/657/EC as regards ion transition ratio criteria and procedures for the validation of analytical methods satisfied by MS/MS.

Blank apple juice samples were tested for interference and selectivity. Matrix effects (SSE) that evaluate a possible suppression or enhancement of the signal was obtained comparing the slope of mycotoxins calibration curves prepared by spiking blank apple juice samples extract with the slope of calibration curves prepared in methanol. SSE (%) were calculated as follows: SSE (%) = 100× slope of curve in extracted matrix/slope of curve in methanol.

Matrix matched standards were used to compensate the signal suppression/enhancement (SSE) of matrix effects. Evidence for relative matrix effects have been registered for mycotoxins in apple juice as signal suppression (from 41--64%) was observed for α-ZOL, AFB1, AFG1, AFG2, OTA, ENNA1, ENNB1, and BEA. Therefore, matrix-matched calibration curves were used for effective quantification of samples. Matrix-matched calibration curves were prepared by spiking blank juice samples at concentrations between LOQs and 1000 μg/L.

The recoveries were obtained by spiking blank apple juice samples before and after the extraction procedure with the studied mycotoxins at three concentration levels (50, 100 and 200 µg/L) in three replicates. The values obtained ranged from 61 to 115%. To obtain Intra-day precision, three determinations were performed in the same day and in three of non-consecutive days for Inter-day precision. The intra-day and inter-day precision were lower than 14% and 19%, respectively, for all studied mycotoxins.

The LODs and LOQs were determined spiking blank apple juice samples, at decreasing concentrations of analyzed mycotoxins using the criterion for both transitions predetermined per each mycotoxin of S/N ≥ 3 for calculate LOD and S/N ≥ 10 for LOQ. LODs obtained ranged from 0.15 to 2.34 μg/L and the LOQs from 0.5 to 7.81 μg/L. The relative error between prepared concentrations and the obtained ones ranged between 20% at LOQs and 16% at 1000 μg/L.

Linearity and matrix effects were studied using standard solutions in neat solvent and matrix-matched calibrations. Calibration curves in both pure solvent and matrix were constructed by plotting the analyte relative ion intensity against the concentration at eight concentration levels (from LOQs to 1000 µg/L). Regression coefficients obtained were higher than 0.990 in all cases. In everyday practice the calibration curve was constructed from a single lot of apple matrix. The degree of how SSE might vary in orange juice and pineapple matrixes was also evaluated. The relative errors between the obtained SSEs in the studied matrixes were lower than 18%. Due to the significant values obtained of SSEs, this parameter has been taken account and matrix matched curves were used for quantification.

The here proposed methodology is presented as a sensitive and robust analytical tool for the simultaneous determination of thirty mycotoxins in juice samples.

2.2. Mycotoxin Contents in Juices {#sec2dot2-toxins-11-00684}
---------------------------------

Only 9 of the 30 analyzed mycotoxins were detected in quantifiable amounts in 49% of the analyzed juices, mainly AOH, AME, PAT, OTA, AFB1, AFB2, AFG2, β-ZAL and HT-2. AOH and PAT, were the most detected mycotoxins with incidences of 29% and 18%, respectively, while β-ZAL and HT-2 were detected in only 3% of the samples ([Table 2](#toxins-11-00684-t002){ref-type="table"}). The results obtained are consistent with the information available in bibliography, where PAT, AOH and AME are the most common mycotoxins found in fruit juices \[[@B2-toxins-11-00684]\]. Chromatograms of real samples contaminated by PAT at 28.37 µg/L and AOH at 441.5 µg/L, respectively are shown in [Figure 1](#toxins-11-00684-f001){ref-type="fig"}.

Regarding the contents determined, the mean of positive samples ranged from 3.75 to 207.01 µg/L. AOH and PAT were also the mycotoxins detected with the higher contents ([Table 2](#toxins-11-00684-t002){ref-type="table"}).

The co-occurrence of mycotoxins was found in 9 analyzed samples (12%). Two apple juices showed co-occurrence of two mycotoxins (AOH + β-ZAL and ΒZAL + PAT)**.** The most prevalent co-occurrence was AOH, AME and AFB1, detected simultaneously in 3 samples (2 samples of pineapple juices and one of peach juice) and coexistence of 7 mycotoxins was observed in two samples of fresh orange juice contaminated by AOH, AME, AFB1, AFB2, AFG2, OTA, PAT. Sum of mycotoxins concentrations quantified in the same sample are listed in [Table 3](#toxins-11-00684-t003){ref-type="table"}. Although the sum of mycotoxins amounts in multi-contaminated samples cannot yet be used to obtain significant interpretations of the risk assessment, the results obtained provide data on the combined and simultaneous exposure to mycotoxins through juice intake. The natural co-occurrence of multiple mycotoxins in food products is an increasing health concern due to the exposure to multiple fungal growths. Very scarce data related to in vivo toxicity evaluation of exposure to combined mycotoxins are available in literature but in line with the in vitro observations, possible additive or synergistic effect may be registered, but, the impact of this effects usually rely on the concentration and duration of exposure \[[@B18-toxins-11-00684]\].

PAT was detected in juices with incidence of 18%, concentrations ranged between \< LOQ to 50.95 µg/L and mean of positive samples was about 28.18 µg/L. Only one sample, exceeded slightly the maximum limit set for PAT by the European Commission in fruit juices (50 µg/L) \[[@B12-toxins-11-00684]\]. In Malaysia, Lee et al. \[[@B4-toxins-11-00684]\] found to be PAT positive 5% of 56 analyzed fruit juices in a range of concentration between 13.1 and 33.7 µg/L. In Iran, Rahimi et al. \[[@B19-toxins-11-00684]\] revealed also PAT presence in 16% of 161 fruit juices samples with levels between 5 to 190.7 µg/kg and mean of positives of 34.5 µg/kg. Contrary to the present study, in Tunisia, Zouaoui et al. \[[@B20-toxins-11-00684]\] reported PAT incidence of 50% in 214 samples of fruit juices, compote and jam samples and concentrations ranging from 2 to 889 µg/L and a mean of 89 µg/L. In Pakistan, Iqbal et al. \[[@B8-toxins-11-00684]\] also reported PAT incidence of 57.4% in 237 samples of fruits, juices, and smoothies, with concentrations ranging from 0.04 to 1100 µg/kg.

OTA was determined in 9% of the studied samples at concentrations between 2.93 and 10.81 µg/L. The European Commission has set 2 µg/kg as a limit for OTA on grape juice. In Turkey, Akdeniz et al. \[[@B3-toxins-11-00684]\] found to be positive 20% of 10 grape juice samples with concentrations ranging from 0.9 to 1.9 µg/kg. Asadi et al. \[[@B7-toxins-11-00684]\] also reported lower contents of OTA in 15% of 20 apple juices and 25% of 20 grape juices, ranging from 0.06 to 0.1 µg/L and 0.06 to 0.12 µg/L, respectively.

AME and AOH were detected in 10 and 29% of the analyzed samples at mean concentration of 8.5 and 207 µg/L, respectively. In the study performed by Zwickel et al. \[[@B6-toxins-11-00684]\], AOH and AME were reported at similar incidence (27 and 5% of 78 juice samples) respectively from the German market, similar incidences to the present work, but at lower contents: AOH (from 0.81 to 8.16 µg/L) and AME (from 0.89 to 1.54 µg/L). Myresiotis et al. \[[@B5-toxins-11-00684]\] did not report AOH and AME presence in any of the pomegranate fruit and juice samples purchased from Greek markets, neither Ruan et al. \[[@B16-toxins-11-00684]\] did detect them in commercial fruit juices from the local market of Guangzhou (China).

AFB1, AFB2 and AFG2 were detected in 8, 6 and 4% of the analyzed samples, respectively at levels in the range of 1.24 and 18.1 µg/L. In a study performed in Egypt, Abdel-Sater et al. \[[@B21-toxins-11-00684]\] reported that 100% of five apple beverages resulted positive for AFB1 and AFG1 in a range from 20 to 30 µg/L and two of five guava juices presented AFB1 at 12 µg/L.

Only 2 apple juice samples of 80 samples resulted contaminated by β-ZAL with concentrations of 22.59 and 23.85 µg/L, respectively. Scarce information is available in the literature about the presence of ZEA and its metabolites in fruit juices. In a prior study, Carballo et al. \[[@B9-toxins-11-00684]\] did not find ZEA and β-ZAL presence in a multimycotoxin study performed in 42 samples of fruit juices. Abdel-Sater et al. \[[@B21-toxins-11-00684]\] also found no ZEA presence in fruit juices and beverages. The same case was observed for HT-2, that only was present in 2 samples of mixed fruit juices with concentrations of 21.38 and 24.15 µg/L, respectively. HT-2 is also not commonly found in fruits and its derived products and little information is available in bibliography. López et al. \[[@B22-toxins-11-00684]\] detected HT-2 in apple juice composite but at levels below the LOQ.

Comparing the results per type of juice samples, mono-fruit juice samples presented contamination up to 8 different mycotoxins (AOH, AME, PAT, AFB1, AFB2, AFG2, OTA, β-ZAL) at levels below 50 µg/L, while blended beverages presented contamination by AOH, PAT and HT-2 ([Table 4](#toxins-11-00684-t004){ref-type="table"}). However, the contents of AOH, the most detected mycotoxin and with the highest levels, were higher in blended beverages, maybe for the addition of other ingredients, like ginger, vegetables as cucumber and spinach or passion fruits. In the case of Ginger, even that its essential oils may inhibit fungal growth, some authors reported ginger contamination by mycotoxins specially OTA and AFs \[[@B23-toxins-11-00684]\]. Vegetables like tomato or red fruits have also been reported contaminated by AOH \[[@B24-toxins-11-00684],[@B25-toxins-11-00684]\]. Juan et al. \[[@B26-toxins-11-00684]\] also reported AOH in strawberry samples up to 752 µg/kg, amounts similar to those reported in the present study. Fresh orange juice samples resulted the most contaminated juice mainly by PAT, AME and AFB2 even at trace levels. AME was previously detected in 11% of citrus juices samples at concentration levels between 0.11 and 0.20 µg/kg \[[@B27-toxins-11-00684]\]. Juan et al. \[[@B28-toxins-11-00684]\] reported AFs, OTA, AOH and AME contamination with mean concentration of 26.12, 0.68, 18.7 and 160.5 µg/L, respectively in berry juices.

2.3. Dietary Exposure to Mycotoxins through Fruit Juices Consumption in Children and Adult Population. {#sec2dot3-toxins-11-00684}
------------------------------------------------------------------------------------------------------

With the purpose to evaluate the exposure of children and adult population to mycotoxins through the consumption of fruit juices, the Estimate Daily Intakes (EDIs) were calculated and compared with the Tolerable Daily Intakes (TDIs).

The European Commission has established TDIs for OTA, PAT, and HT2 and βZAL. A provisional maximum tolerable daily intake of 0.4 µg/kg bw/day has been fixed for PAT \[[@B29-toxins-11-00684]\], a TDI of 0.25 µg/kg bw/day for ZEA and of 0.1 µg/kg bw/day for the sum of HT2 and T2 have been set \[[@B30-toxins-11-00684]\]. Tolerable Weekly Intake (TWI) of 0.12 µg/kg bw/week has been also fixed for OTA \[[@B31-toxins-11-00684]\].

The EDIs (μg/kg bw/day) for each mycotoxin were calculated by following formula = C × K/bw where C is the mean concentration of each mycotoxin in juice (µg/L), K is the daily average of juice consumption per person (L/day) and bw is the bodyweight used for the population group.

Left-censored results (data below LOQ) were processed according to EFSA recommendations considering two exposure scenarios \[[@B32-toxins-11-00684]\]. In the lower bound scenario (LB) zero was assigned when mycotoxins were not detected or were detected below the limit of quantification. In the upper bound (UB) scenario, the limit of detection was assigned when mycotoxins were not detected, and the limit of quantification when mycotoxins were detected at levels below LOQ.

A bodyweight of 70 kg was considered for adult population and of 25 kg for children population. The daily consumption of juice extracted from the database of the Spanish Ministry of Agriculture, Fisheries and Food was on average of 9.2 L per year/per person \[[@B33-toxins-11-00684]\]. Children populations are higher consumers of juices and a daily consumption of 200 mL corresponding to single portion was considered for a more realistic approach.

Considering the mean of positive samples as mean concentration, the EDIs obtained represented a notable percentage of TDIs fixed ([Table 5](#toxins-11-00684-t005){ref-type="table"}). For adult population, percentages of (2.5% TDI), (11.5% TDI), (3.3% TDI) and (8.2% TDI) were respectively obtained for PAT, OTA, βZAL and HT-2. However, when the mean of total samples was used, the EDIs values obtained for adult population were far below the TDIs fixed, representing less than 2% of TDIs, in both LB and UB approaches.

For children, exposure rate of 56.4% TDI for PAT and 74.3% TDI for βZAL, and EDIs over than the fixed TDI for OTA and HT-2 were obtained with mean of positive samples. This data lowered to 13.8% of PAT TDI, 35.3% of OTA TDI, 9.15% of βZAL TDI and 9% of HT-2 TDI in UB scenario when the mean used was of the whole samples. These results evidenced an increasing risk for children.

Comparing these results with those obtained by Torovic et al. \[[@B34-toxins-11-00684]\] in a study of risk assessment of patulin intake through apple juices in infants and preschool children in Serbia, similar risk exposure was observed by these authors after considering the same daily juice consumption of 0.2 L and the mean of total samples. In this case, the obtained values of EDI for preschool children reached the 6% of the TDI established for PAT, considering different scenarios for left censored results.

3. Conclusions {#sec3-toxins-11-00684}
==============

The analytical procedure employed was suitable for the analysis of 30 mycotoxins in the studied juice samples. The mycotoxins determined in the present study such as AOH, AME, and PAT were the most commonly reported in the literature. The main mycotoxins incidences and means in positive samples were lower than 30% and 28.18 µg/L, respectively. AOH was related to the higher mean detected (207 µg/L). A total of 12% of analyzed samples presented coexistence from 2 mycotoxins to 7 mycotoxins. The EDIs calculated for OTA and HT-2 overlapped the established TDIs when the mean of positives samples was considered for risk assessment for children, decreasing to unconcerned levels when the LB and UB scenarios where employed.

4. Materials and Methods {#sec4-toxins-11-00684}
========================

4.1. Reagents and Chemicals {#sec4dot1-toxins-11-00684}
---------------------------

Solvents (acetonitrile, methanol, and chloroform) were supplied by Merck (Darmstadt, Germany). Ethyl acetate was supplied by Alfa Aesar (Karlsruhe, Germany). Deionized water (resistivity \> 18 MΩ cm^−1^) was obtained in the laboratory using a Milli-Q SP^®^ Reagent Water System (Millipore Corporation, Bedford, MA, USA). Ammonium formate (99%) was supplied by Panreac Quimica S.A.U. (Barcelona, Spain). Formic acid (reagent grade ≥ 95%) was obtained from Sigma Aldrich (St. Louis, MO, USA). Nylon filters (0.45-μm pore size) were supplied by Scharlau (Barcelona, Spain). Syringe nylon filters (13 mm diameter and 0.22-μm pore size) were obtained from Membrane Solutions (Plano, TX, USA). The derivatization reagent composed of BSA (N,O-bis(trimethylsilyl) acetamide) + TMCS (trimethylchlorosilane) + TMSI (N-trimethylsilylimidazole) (3:2:3) was obtained from Supelco (Bellefonte, PA, USA). Disodium phosphate and Sodium dihydrogen phosphate, used to prepare phosphate buffer, were obtained from Panreac.

The standards of AFB1, AFB2, AFG1, AFG2, AOH, AME, OTA, FB1, FB2, ENNA, ENNA1, ENNB, ENNB1, BEA, STG, ZEA, α-ZAL, β-ZAL, α-ZOL, β-ZOL, DON, 3-ADON, 15-ADON, DAS, NIV, FUS-X, NEO, PAT, T-2 and HT-2 toxins were purchased from Sigma Aldrich. Individual stock solutions were prepared to obtain 100 mg/L in methanol and working solutions were obtained diluting the individual stock solutions. All solutions were stored in darkness and kept at −20 °C.

4.2. Sampling {#sec4dot2-toxins-11-00684}
-------------

A total of 80 commercial juices were collected from various supermarkets of Valencia (Spain) during 2018. The samples were classified into two groups. 40 were mono-fruit; 7 were filtered orange juices with nothing added, and 33 resulting from concentrated, sweetened drinks made from fruit pulpe, where 3 were from orange, 4 from pear, 12 from apple and 7 were from pineapple and peach respectively.

40 blended beverages, containing fruit juices and mashed vegetables and, sometimes incorporating dairy or functional ingredients (e.g., chia seeds). In this group, 5 samples held ecological label, 24 health claims label and 11 common label. The composition of each sample is detailed in [Table S1](#app1-toxins-11-00684){ref-type="app"}. The samples were stored in darkness and dry place until analysis.

4.3. Dispersive Liquid-Liquid Microextraction Procedure (DLLME) {#sec4dot3-toxins-11-00684}
---------------------------------------------------------------

The samples were extracted according to Carballo et al., \[[@B9-toxins-11-00684]\]. 5 mL of each juice sample were placed with 1 g of NaCl in a 10 mL conical tube, and the tube was shaken in vortex for one minute. After vortexing, a mixture of dispersion solvent (950 μL of acetonitrile) and extraction solvent (620 μL of ethyl acetate) was added and the tube was shaken in vortex for one minute, resulting in a cloudy solution of the three components. Then the mixture was centrifuged at 4000 rpm for 5 min, and 600 μL of the organic phase located at the top of the tube was separated and placed into other conical tube. Next, in a second step the mixture of dispersion solvent (950 μL of methanol) and extraction solvent (620 μL of chloroform) was added to the remaining residue in the tube. After centrifugation, 600 μL of the organic phase, located in this case in the bottom of the tube was recovered and added to the first organic phase separated before. Then the two recovered phases were evaporated to near dryness under a nitrogen stream using a Turvovap LV Evaporator (Zymark, Hoptikinton, MA, USA).

For LC-MS/MS analysis, the residue was reconstituted with 1 mL of 20 mM ammonium formate (MeOH/ACN) (50/50 v/v) and filtered through a 13 mm/0.22 μm nylon filter in a vial while for GC-MS/MS analysis, a derivatization process was carried out by adding 50 μL of BSA + TMCS + TMSI (3:2:3) to the dry extract and left at room temperature 30 min. Then 200 μL of hexane was added, mixed in vortex for 30 s, washed with 1 mL of phosphate buffer (60 mM, pH7) and mixed until the upper layer was clear. Finally, the hexane layer (200 µL) was transferred to an auto sampler vial.

4.4. LC-MS/MS Determination {#sec4dot4-toxins-11-00684}
---------------------------

The determination was performed using an Agilent 1200 chromatograph (Agilent Technologies, Palo Alto, CA, USA) equipped with 3200 QTRAP^®^ (Applied Biosystems, AB Sciex, Foster City, CA, USA) with turbo ion spray electrospray ionization (ESI). The QTRAP analyser combines a fully functional triple quadrupole and a linear ion trap mass spectrometer. The chromatographic separation of analytes was performed in a Gemini-NX column C~18~ (Phenomenex, 150 mm × 4.6 mm, 5 particle size) preceded by a guard column. Mobile phases were 5 mM ammonium formate, 0.1% formic acid in water (mobile phase A) and 0.1% formic acid in methanol (mobile phase B). The elution gradient initiated with a proportion of 0% for eluent B; in 10 min increased to 100%, then decreased to 80% in 5 min, and finally decreased to 70% in 2 min. In the next 6 min, the column was cleaned, readjusted to initial conditions, and equilibrated for 7 min. The flow rate was established at 0.25 mL/min, and the oven temperature at 40 °C.

The analysis was performed using the Turbo-ion spray in the positive ionization mode (ESI+). Nitrogen was served as nebulizer and collision gas. During the analysis, the following parameters were fixed: probe temperature 450 °C; ion spray voltage 5500 V; curtain gas 20 arbitrary units; GS1 and GS2, 50 and 50 psi, respectively.

The transitions used for the quantification and confirmation of the monitored fragments are shown in [Table 1](#toxins-11-00684-t001){ref-type="table"}.

4.5. GC-MS/MS Determination {#sec4dot5-toxins-11-00684}
---------------------------

An GC system Agilent 7890A coupled with an Agilent 7000A triple quadruple mass spectrometer with inter electron-impact ion source (EI, 70Ev) and Agilent 7693 auto sampler (Agilent Technologies, Palo Alto, USA) was used for the determination. Quantitation data were acquired at selection reaction monitoring mode (SRM). The transfer line and source temperatures were 280° and 230°, respectively. Nitrogen was used as collision gas for MS/MS experiments, and helium was used as quenching gas, both at 99.999% purity supplied by Carburos Metálicos S.L. (Barcelona, Spain). A capillary column HP-5MS 30m × 0.25mm × 0.25μm was used for the separation of analytes. One microliter of the final clean derivatized extract of mycotoxins was injected in splitless mode in the programmable temperature vaporization (PTV) inlet at 250 °C, employing helium as carried gas at fixed pressure of 20.3 psi. Oven temperature started at 80 °C, and increased to 245 °C at 60 °C/min, hold their time for 3 min and progressively increased to 260 °C by 3 °C/min and finally to 270 °C at 10 °C/min and then held for 10 min. Agilent Mass hunter version B.04.00 software was employed to acquire and process data.

The research was supported by Ministry of Education, Research, Culture and Sports (AICO/2018/199) and by the pre-PhD program of University of Valencia "Atracció de Talent" (UV-INV-PREDOC16F1-384781).

The following are available online at <https://www.mdpi.com/2072-6651/11/12/684/s1>, Table S1: Description of the analyzed samples.
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![Chromatograms of contaminated samples with (**a**) patulin (PAT) (28.37 µg/L) and (**b**) AOH (441.5 µg/L) determined by GC-MS/MS and LC-MS/MS, respectively.](toxins-11-00684-g001){#toxins-11-00684-f001}

toxins-11-00684-t001_Table 1

###### 

Quantification and confirmation transitions of mycotoxins monitored fragments, retention time (Rt)) and analytical parameters obtained.

  Mycotoxin     Quantification Transition   Confirmation Transition   Rt      SSE (%) ^c^   LOD    LOQ    Recovery (%)         
  ------------- --------------------------- ------------------------- ------- ------------- ------ ------ -------------- ----- -----
  ZEA ^a^       462 \> 151                  462 \> 333                15.95   115           2.34   7.81   98             113   103
  α-ZAL ^a^     433 \> 309                  433 \> 295                15.45   88            0.58   1.95   101            97    99
  β-ZAL ^a^     433 \> 295                  307 \> 73                 15.68   91            2.34   7.81   97             105   104
  α-ZOL ^a^     305 \> 73                   305 \> 289                16.45   62            0.58   1.95   80             113   95
  β-ZOL ^a^     536 \> 333                  536 \> 446                16.82   69            1.17   3.90   98             102   69
  DON ^a^       392 \> 259                  407 \> 197                8.4     103           0.58   1.95   68             72    63
  3-ADON ^a^    392 \> 287                  467 \> 147                9.68    88            1.17   3.90   103            103   105
  15-ADON ^a^   392 \> 217                  392 \> 184                9.65    114           0.58   1.95   95             98    96
  DAS ^a^       350 \> 229                  378 \> 124                9.85    96            1.17   3.90   103            91    84
  NIV ^a^       289 \> 73                   379 \> 73                 10.15   87            1.17   3.90   61             88    97
  FUS-X ^a^     450 \> 260                  450 \> 245                9.73    106           2.34   7.81   84             98    106
  NEO ^a^       252 \> 195                  252 \> 167                11.68   95            0.58   1.95   83             71    69
  PAT ^a^       226 \> 73                   183 \> 75                 4.3     78            2.34   7.81   61             96    92
  T-2 ^a^       350 \> 259                  350 \> 229                14.8    71            2.34   7.81   98             96    71
  HT-2 ^a^      347 \> 157                  347 \> 185                14.39   78            0.58   1.95   106            107   78
  AFB1 ^b^      313 \> 285                  313 \> 241                7.41    48            0.3    1.0    111            64    115
  AFB2 ^b^      315 \> 287                  315 \> 259                7.36    80            0.3    1.0    83             71    69
  AFG1 ^b^      329 \> 243                  329 \> 311                7.23    60            0.3    1.0    63             76    83
  AFG2 ^b^      331 \> 313                  331 \> 245                7.13    41            0.3    1.0    79             70    92
  AOH ^b^       259 ˃ 128                   258 ˃ 184                 8.01    67            0.3    1.0    105            114   90
  AME ^b^       273 ˃ 128                   273 ˃ 228                 9.10    120           0.3    1.0    78             89    71
  OTA ^b^       404 \> 239                  404 \> 102                8.68    64            0.3    1.0    90             73    71
  FB~1~ ^b^     722 ˃ 334                   722 ˃ 352                 7.7     75            1.5    5.0    65             86    82
  FB~2~ ^b^     706 ˃ 336                   706 ˃ 318                 7.85    67            1.5    5.0    75             94    79
  ENNA ^b^      699 \> 210                  699 \> 228                11.74   73            0.3    1.0    96             67    78
  ENNA1 ^b^     685 \> 210                  685 \> 214                11.3    60            0.3    1.0    109            66    87
  ENNB ^b^      657 \> 196                  657 \> 214                10.73   66            0.15   0.5    104            66    85
  ENNB1 ^b^     671 \> 214                  671 \> 228                10.68   54            0.3    1.0    110            67    81
  BEA ^b^       801 \> 784                  801 \> 244                10.84   52            1.5    5.0    112            65    82
  STG ^b^       325 \> 281                  325 \> 310                9.08    106           1.5    5.0    62             66    71

^a^ GC-MS/MS determination. ^b^ LC-MS/MS determination. ^c^ SSE: Signal Suppression-Enhancer.
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###### 

Mycotoxins ranges and means found in the analyzed samples (μg/L).

  MYCOTOXIN   Mean of Positive Samples   Minimum Concentration   Maximum Concentration   Incidence (%)   Lower Bound Scenario ^a^   Upper Bound Scenario ^b^
  ----------- -------------------------- ----------------------- ----------------------- --------------- -------------------------- --------------------------
  AFB1        9.36                       4.68                    18.1                    4               0.35                       0.64
  AFB2        4.49                       1.38                    12.49                   6               0.28                       0.56
  AFG2        3.75                       1.24                    7.60                    4               0.14                       0.43
  AME         8.54                       2.47                    15.18                   10              0.85                       1.124
  AOH         207                        \< LOQ                  1213                    29              59.50                      59.73
  βZAL        23.22                      22.59                   23.85                   3               0.58                       2.86
  HT2         22.76                      21.38                   24.15                   3               0.57                       1.13
  OTA         5.43                       2.93                    10.81                   9               0.48                       0.75
  PAT         28.18                      \< LOQ                  50.95                   18              4.93                       6.9

^a^ Lower bound scenario: Mean assigning zero to not detected mycotoxins or mycotoxins detected below their corresponding LOQ. ^b^ Upper bound scenario: Mean assigning the LOD to not detected mycotoxins, and the corresponding LOQ to mycotoxins detected at levels below LOQ.
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###### 

Sum of mycotoxins concentrations in multi-contaminated samples (µg/L).

  Mycotoxins Co-occurrence                                          Number of Samples   Sum of Concentrations
  ----------------------------------------------------------------- ------------------- -----------------------
  AOH + β-ZAL (apple juice)                                         1                   24.86
  ΒZAL + PAT (apple juice)                                          1                   50.96
  AOH + AME+AFB1 (pineapple juice, peach juice)                     3                   9.36--36.2
  AME + AFB2 + AFG2 + OTA + PAT (fresh orange juice)                1                   33.3
  AME + AFB1 + AFB2 + OTA + PAT (fresh orange juice)                1                   71.33
  AOH + AME + AFB1 + AFB2 + AFG2 + OTA + PAT (fresh orange juice)   2                   65.47--97.36

toxins-11-00684-t004_Table 4

###### 

Mycotoxin incidence, concentration range and mean of positive samples (µg/L).

  Mycotoxin   Mono-Fruit Juices (n = 40)   Blended Beverages (n = 40)                                                                                                                                                           
  ----------- ---------------------------- ---------------------------- -------------- ------- -------------- -------------- ----- -------------- --------------- ------ ---------------- --------------- ------ -------------- --------------
  AFB1        3/7                          9.37 ± 3.03                  5.93--11.65    3/33    9.77 ± 7.3     4.68--18.1     nd    \-\--          \--             nd     \--              \--             nd     \--            \--
  AFB2        5/7                          4.49 ± 4.53                  1.38--12.49    nd      \-\--          \--            nd    \-\--          \--             nd     \-\--            \--             nd     \-\--          \--
  AFG2        3/7                          3.76 ± 3.4                   1.24--7.6      nd      \-\--          \--            nd    \-\--          \--             nd     \-\--            \--             nd     \-\--          \--
  AME         5/7                          9.53 ± 2.05                  7.03--11.77    3/33    6.87 ± 7.2     2.47--15.18    nd    \-\--          \--             nd     \-\--            \--             nd     \-\--          \--
  AOH         2/7                          3.59 ± 3.14                  1.37--5.81     11/33   3.71 ± 3.55    \<LOQ--11.16   2/5   629.74 ± 266   441.5--817.98   8/24   528.01 ± 362.9   93.5--1213.87   nd     \-\--          \--
  Β-ZAL       nd ^b^                       \-\--                        \--            2/33    23.22 ± 0.89   22.59--23.85   nd    \-\--          \--             nd     \-\--            \--             nd     \-\--          \--
  HT2         nd                           \-\--                        \--            nd      \-\--          \--            nd    \-\--          \--             nd     \-\--            \--             2/11   22.77 ± 1.95   21.38--24.15
  OTA         5/7                          6.25 ± 3.93                  2.93--10.81    2/33    3.4 ± 0.38     3.13--3.67     nd    \-\--          \--             nd     \-\--            \--             nd     \-\--          \--
  PAT         7/7                          34.59 ± 13.9                 14.78--50.59   5/33    28.34 ± 14     8.05--47.82    nd    \-\--          \--             nd     \-\--            \--             2/11   10.89 ± 0      \<LOQ--10.89

^a^ Incidence (number positive samples/number total samples). ^b^ not detected.
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###### 

Mycotoxin risk assessment through fruit juices consumption for children and adult population.

  Mycotoxin   TDI (ng/kg bw)   Positive Samples   Lower Bound Scenario   Upper Bound Scenario                                                                
  ----------- ---------------- ------------------ ---------------------- ---------------------- ------- ------- ------ ------- ------ ------- ------ ------- ------
  PAT         400              225.44             10.15                  56.36                  2.54    39.20   1.76   9.80    0.44   55.20   2.48   13.80   0.62
  OTA         17               43.44              1.96                   255.53                 11.50   3.84    0.17   22.59   1.02   6.00    0.27   35.29   1.59
  B-ZAL       250              185.76             8.36                   74.30                  3.34    4.64    0.21   1.86    0.08   22.88   1.03   9.15    0.41
  HT-2        100              182.08             8.20                   182.08                 8.20    4.56    0.21   4.56    0.21   9.04    0.41   9.04    0.41
